Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,367 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Completed

Using MASL to Combat Oral Cancer

NCT04188665

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
Locations
  • New Jersey Medical School Newark, New Jersey, United States
  • Rutgers School for Dental Medicine Newark, New Jersey, United States
  • University Hospital Newark, New Jersey, United States
  • Rowan University Stratford, New Jersey, United States
View Trial Details
Completed

A Study of MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)

NCT06894771

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +45 more
Locations
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0301) Hackensack, New Jersey, United States
  • NEXT Oncology ( Site 0300) San Antonio, Texas, United States
  • Princess Margaret Cancer Center ( Site 0101) Toronto, Ontario, Canada
  • Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0102) Québec, Quebec, Canada
View Trial Details
Completed

A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010/LEAP-010)-China Extension

NCT05523323

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Anhui Cancer Hospital-Radiology Department ( Site 3333) Hefei, Anhui, China
  • Beijing Tongren Hospital affiliated to Capital Medical University ( Site 3343) Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital ( Site 3314) Beining, Beijing Municipality, China
  • Peking Union Medical College Hospital ( Site 3304) Bejiing, Beijing Municipality, China
View all 28 locations
View Trial Details
Completed

Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab

NCT00939627

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +49 more
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Suburban Hospital Bethesda, Maryland, United States
View Trial Details
Completed

Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

NCT00003809

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Beckman Research Institute, City of Hope Los Angeles, California, United States
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
View all 76 locations
View Trial Details

Related conditions